12:20 – 13:50
Lunch Satellite Symposium
The evolving knowledge in the systemic treatment of NSCLC
Supported by Eli Lilly and Company
Located in Auditorium G Agnelli
18:10 – 19:10
Evening Satellite Symposium
Gefitinb the 1st personalized therapy that has changed the paradigm for the pathway of NSCLC EGFRm+
Supported by AstraZeneca
Located in Auditorium G Agnelli
11:50 – 13:20
Lunch Satellite Symposium
Putting evidence into practice: Optimising outcomes for patients with NSCLC
Supported by Supported by F. Hoffmann-La Roche Ltd
Located in Auditorium G Agnelli
©2011 Imedex®, LLC. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.